Halozyme Therapeutics (HALO) EBT (2010 - 2026)
Halozyme Therapeutics (HALO) reported EBT of $284.9 million for Q2 2026, up 39.0% from $204.94 million a year earlier and up 58.0% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) EBT (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Halozyme Therapeutics' EBT came in at $583.34 million, down 15.7% year-over-year; for FY2025, it was $466.88 million, down 16.2% from FY2024.
- EBT has a five-year compound annual growth rate of 29.3% (FY2020 to FY2025).
- By year, EBT came in at $557.13 million in FY2024 (+59.9%), $348.33 million in FY2023 (+39.9%), $248.92 million in FY2022 (+0.2%) and $248.52 million in FY2021 (+92.2%).
- The Q2 2026 figure ranks as the highest quarterly EBT in data going back to Q2 2010.
- The high point for year-over-year EBT in five years was Q2 2023 (growth of 210.4%); the low point was Q2 2022 (a decline of 67.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $180.33 million (Q1 2026), -$100.85 million (Q4 2025) and $218.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.39 Bn |
| 10 | Halozyme Therapeutics | 12.72 Bn | 11.33 Bn | 401.83 Mn | 284.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 284.90 Mn |
| Mar 31, 2026 | 180.33 Mn |
| Dec 31, 2025 | -100.85 Mn |
| Sep 30, 2025 | 218.96 Mn |
| Jun 30, 2025 | 204.94 Mn |
| Mar 31, 2025 | 143.83 Mn |
| Dec 31, 2024 | 178.21 Mn |
| Sep 30, 2024 | 165.15 Mn |
| Jun 30, 2024 | 117.74 Mn |
| Mar 31, 2024 | 96.03 Mn |
| Dec 31, 2023 | 101.18 Mn |
| Sep 30, 2023 | 101.76 Mn |
| Jun 30, 2023 | 93.16 Mn |
| Mar 31, 2023 | 52.24 Mn |
| Dec 31, 2022 | 70.79 Mn |
| Sep 30, 2022 | 73.71 Mn |
| Jun 30, 2022 | 30.01 Mn |
| Mar 31, 2022 | 74.41 Mn |
| Dec 31, 2021 | 54.81 Mn |
| Sep 30, 2021 | 74.11 Mn |
API Access
Halozyme Therapeutics EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();